Global Corneal Transplant Market

Corneal Transplant Market Size, Share, Growth Analysis, By Indications(Fungal corneal ulcer, Bullous keratopathy, Keratoconus, Keratitis), By Type(Penetrating keratoplasty, Endothelial keratoplasty, Descemet stripping automated endothelial keratoplasty (DSAEK), Corneal graft), By End-user(Hospitals, Eye clinics, and Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2814 | Region: Global | Published Date: July, 2024
Pages: 219 | Tables: 96 | Figures: 66

Corneal Transplant Market News

  • In April 2024, NHS Blood and Transplant (NHSBT) is initiating its inaugural cornea partnership with the renowned national optician chain, Specsavers, to emphasize the critical need for increased cornea donations. Collaborating with one of the largest and most esteemed retail brands, NHSBT intends to heighten understanding about the significance of corneal donation in facilitating the restoration of vision for numerous individuals awaiting corneal transplants throughout the UK. 
  • In January 2023, a Korean collaborative research group unveiled a novel tissue adhesive capable of repairing damaged corneas with a straightforward process of filling and light exposure. This innovative adhesive, unlike its predecessors, seamlessly integrates with surrounding tissues and facilitates tissue reconstruction within just three minutes of visible light irradiation.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Corneal Transplant Market size was valued at USD 455.8 million in 2022 and is poised to grow from USD 489.99 million in 2023 to USD 873.88 million by 2031, growing at a CAGR of 7.5% in the forecast period (2024-2031). 

The competitive environment of the global Corneal Transplant market  is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.  'Carl Zeiss Meditec AG (Germany) ', 'Alcon, Inc. (Switzerland) ', 'Bausch & Lomb Incorporated (United States) ', 'Abbott Medical Optics, Inc. (United States) ', 'CooperVision, Inc. (United States) ', 'STAAR Surgical Company (United States) ', 'Topcon Corporation (Japan) ', 'Johnson & Johnson Vision Care, Inc. (United States) ', 'Lumenis Ltd. (Israel) ', 'NIDEK Co., Ltd. (Japan) ', 'Haag-Streit AG (Switzerland) ', 'Ziemer Ophthalmic Systems AG (Switzerland) ', 'Essilor International S.A. (France) ', 'Allergan, Inc. (Ireland) ', 'HOYA Corporation (Japan) ', 'Menicon Co., Ltd. (Japan) ', 'Novartis AG (Switzerland) ', 'SynergEyes, Inc. (United States) ', 'Oculus, Inc. (United States) ', 'ZEISS Group (Germany)'

The remarkable growth observed in the market for corneal implants can be primarily attributed to several key factors that collectively contribute to a heightened demand for these advanced medical devices. Notably, technological advancements in corneal implants have played a pivotal role in enhancing their efficacy and applicability in addressing various eye disorders. The escalating prevalence of the geriatric population is another significant driver, as this demographic is particularly susceptible to eye conditions such as Fuchs' dystrophy. The prevalence of late-onset Fuchs' endothelial dystrophy, a condition often affecting individuals over the age of 40, has been highlighted in a March 2020 article published in Progress in Retinal and Eye Research. 

North America is poised for dominance, driven by a rising awareness of eye donation initiatives in the region and the active involvement of numerous organizations. Within North America, the US corneal transplant market has secured the largest market share, underscoring its prominence in the industry. Simultaneously, the corneal transplant market in Canada has demonstrated the fastest growth in the region. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Corneal Transplant Market

Report ID: SQMIG35A2814

$5,300
BUY NOW GET FREE SAMPLE